Lab Automation Market

1. "Laboratory Automation Market: Empowering Scientific Advancements" Worldwide demand for lab automation services experienced a Y-o-Y expansion rate of over 11% in 2022 compared to 2021, rising from US$ 1.8 Billion to US$ 2 Billion. The global lab automation market is segmented into various application, including drug discovery, clinical diagnostics, genomics solutions, and proteomics solutions. Among all the application, clinical diagnostics segment shall dominate the market, accounting for 27.1% of total revenue in 2022. Going forward, the global lab automation market size was valued at US$ 1.8 Billion in 2021, and is poised to reach US$4 Billion by 2032, growing at a CAGR of 7% from 2022 to 2032. Download Sample Copy of This Report:https://www.factmr.com/connectus/sample?flag=S&rep_id=5672?PJ Key Takeaways from Lab Automation Market Study     By product, demand for integrated automated workstations to expand at a rapid pace Biotechnology & pharmaceutical industry experiencing major uptake of lab automation systems By application, drug discovery and clinical diagnostics to collectively capture a lucrative share Voluminous biopharmaceuticals manufacturing to elevate lab automation deployment across the U.S. The U.K. to generate fresh revenue ecosystems amid high reliance on in vitro diagnostics Growing R&D initiatives by government and non-governmental entities bolstering France and Germany’s growth prospects India and China to emerge as lucrative hotspots amid increasing need to offset asymmetries in efficient lab testing mechanisms    R&D Expenditure in the Pharmaceutical Industry Driving Growth of Lab Automation Market According to the Institute for Human Data Science, in 2019, patients around the world received around 1.8 trillion days of therapy, averaging 234 days per person. For instance, the EU Commission, in March 2021, advanced a grant to eTheRNA Immunotherapies, to accelerate the development of a novel and potentially best-in-class therapeutic mRNA cancer vaccine to treat recurrent HPV16+ head and neck cancers. The grant amounted to € 6.9 million. It further estimates that global medicine spending is expected to increase between 2% – 5% annually, exceeding US$ 1 trillion by 2024. While the United States is expected to account for over half of global pharmaceutical industry revenue, key emerging economies, especially India and China, are expected to emerge as the frontrunners of the industry over the coming years, with prolific advances already becoming evident. The majority of the aforementioned players’ primary expansion strategy includes the introduction of new automation equipment and software that can be customized to meet industry-specific requirements. Furthermore, strategic partnerships, collaborations with academic and research institutes, as well as the government, and the acquisition of small-scale players are used.  Thermo Fisher Scientific, Inc. launched the Rapid EZ DNA-Seq library preparation kit in February 2020, offering PCR-free generation of sequencing-ready libraries for NGS. Danaher Corporation (Beckman Coulter, Inc.) signed a marketing agreement with Clever Culture Systems (CCS), a leader in microbiology automation using AI, in July 2020, to promote the APAS Independence in their suite of lab automation solutions. Becton, Dickinson, and Company announced in February 2020 that the BD Kiestra ReadA has been approved by the US Food and Drug Administration (FDA). This stand-alone device increases operational efficiency in clinical microbiology laboratories by automating redundant plate management tasks while providing accuracy via standardized digital image acquisition.  

2. Market Participants              Thermo Fisher Scientific Agilent Technologies PerkinElmer Hudson Robotics Qiagen NV F. Hoffmann-La Roche Ltd. Hamilton Robotics Siemens Healthineers Becton Dickinson and Company Bio-Rad Laboratories FORMULATRIX BioMerieux SA Danaher Corporation Regional Analysis of Lab Automation Market  North America, Europe, Asia Pacific, Latin America, and Middle East & Africa are the major regions considered for the study of the Lab Automation market. North America is expected to dominate the market during the forecast period. Owing to the presence of large pharmaceutical companies, increasing investment in drug discovery and genomics market. The United States is the largest market for biopharmaceuticals, accounting for nearly a third of the global market. Furthermore, the Pharmaceutical Research and Manufacturers Association (PhRMA) says that U.S. firms conduct 50% of the global R&D in pharmaceuticals, amounting to US$ 75 billion. As of 2015, the industry generated over US$ 1.3 trillion in economic output, representing 4% of total revenue. Furthermore, the U.S. has one of the world’s most supportive domestic environments for the development and commercialization of pharmaceuticals, with minimal market barriers.      Key Segments Covered in the Lab Automation Market Report Product Equipment       Automated Workstations Automated Liquid Handling Automated Integrated Workstations Pipetting Systems Reagent Dispensers Microplate Washers Microplate Readers   Multi-mode Microplate Readers Single-mode Microplate Readers Automated ELISA Systems Automated Nucleic Acid Purification Systems Software & Informatics   Workstation/Unit Automation Software Laboratory Information Management Systems (LIMS)

3.   Electronic Laboratory Notebook Scientific Data Management System Application     Drug Discovery Clinical Diagnostics Genomics Solutions Proteomics Solutions The global lab automation report answers numerous pertinent questions, some of which are:   What are some of the latent areas of investments in the market? Which region is expected to emerge as showing the most attractive growth rate during the forecast period and which factors will be crucial to its growth? What trends are likely to change the status quo of the positions held by leading players of the market in the not-so-distant future? Which product/service/technology segments holds game-changing potential to dramatically shape the competitive dynamic in the market? What are the strategies adopted by top players to retain their stronghold in the market? Which strategic moves will new entrants adopt to gain a strong foothold in the market? What are COVID-19 implications on the market and learn how businesses can respond, manage, and mitigate the risks?     